Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2007 1
2008 1
2009 1
2010 2
2011 1
2012 2
2013 2
2014 1
2019 4
2020 4
2021 2
2022 2
2023 5
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

25 results

Results by year

Filters applied: . Clear all
Page 1
Real-world time trends in overall survival, treatments and patient characteristics in HR+/HER2- metastatic breast cancer: an observational study of the SONABRE Registry.
Meegdes M, Geurts SME, Erdkamp FLG, Dercksen MW, Vriens BEPJ, Aaldering KNA, Pepels MJAE, van de Winkel LMH, Peters NAJB, Tol J, Heijns JB, van de Wouw AJ, de Fallois AJO, van Kats MACE, Tjan-Heijnen VCG. Meegdes M, et al. Among authors: pepels mjae. Lancet Reg Health Eur. 2023 Jan 6;26:100573. doi: 10.1016/j.lanepe.2022.100573. eCollection 2023 Mar. Lancet Reg Health Eur. 2023. PMID: 36895447 Free PMC article.
The implementation of CDK 4/6 inhibitors and its impact on treatment choices in HR+/HER2- advanced breast cancer patients: A study of the Dutch SONABRE Registry.
Meegdes M, Geurts SME, Erdkamp FLG, Dercksen MW, Vriens BEPJ, Aaldering KNA, Pepels MJAE, van de Winkel LMH, Teeuwen NJA, de Boer M, Tjan-Heijnen VCG. Meegdes M, et al. Among authors: pepels mjae. Int J Cancer. 2022 Jan 1;150(1):124-131. doi: 10.1002/ijc.33785. Epub 2021 Sep 14. Int J Cancer. 2022. PMID: 34460112 Free PMC article.
The initial hormone receptor/HER2 subtype is the main determinator of subtype discordance in advanced breast cancer: a study of the SONABRE registry.
Meegdes M, Ibragimova KIE, Lobbezoo DJA, Vriens IJH, Kooreman LFS, Erdkamp FLG, Dercksen MW, Vriens BEPJ, Aaldering KNA, Pepels MJAE, van de Winkel LMH, Tol J, Heijns JB, van de Wouw AJ, Peters NAJB, Hochstenbach-Waelen A, Smidt ML, Geurts SME, Tjan-Heijnen VCG. Meegdes M, et al. Among authors: pepels mjae. Breast Cancer Res Treat. 2022 Apr;192(2):331-342. doi: 10.1007/s10549-021-06472-5. Epub 2022 Jan 13. Breast Cancer Res Treat. 2022. PMID: 35025003 Free PMC article.
Trastuzumab Resistance in Patients With HER2-Positive Advanced Breast Cancer: Results From the SONABRE Registry.
Ibragimova KIE, Geurts SME, Laczkó D, Meegdes M, Erdkamp F, Heijns JB, Tol J, Vriens BEPJ, Aaldering KNA, Dercksen MW, Pepels MJAE, Peters NAJB, van de Winkel LMH, van de Wouw AJ, de Fallois A, van Kats MACE, Tjan-Heijnen VCG. Ibragimova KIE, et al. Among authors: pepels mjae. Clin Breast Cancer. 2024 Feb;24(2):103-111. doi: 10.1016/j.clbc.2023.10.009. Epub 2023 Nov 2. Clin Breast Cancer. 2024. PMID: 38007349 Free article.
Survival before and after the introduction of pertuzumab and T-DM1 in HER2-positive advanced breast cancer, a study of the SONABRE Registry.
Ibragimova KIE, Geurts SME, Croes S, Erdkamp F, Heijns JB, Tol J, Vriens BEPJ, Aaldering KNA, Dercksen MW, Pepels MJAE, Peters NAJB, van de Winkel L, Tilli DJP, Vriens IJH, de Boer M, Tjan-Heijnen VCG. Ibragimova KIE, et al. Among authors: pepels mjae. Breast Cancer Res Treat. 2021 Jul;188(2):571-581. doi: 10.1007/s10549-021-06178-8. Epub 2021 Mar 20. Breast Cancer Res Treat. 2021. PMID: 33743103 Free PMC article.
Blended online learning for oncologists to improve skills in shared decision making about palliative chemotherapy: a pre-posttest evaluation.
Bos-van den Hoek DW, van Laarhoven HWM, Ali R, Bakker SD, Goosens A, Hendriks MP, Pepels MJAE, Tange D, de Vos FYFL, van de Wouw AJ, Smets EMA, Henselmans I. Bos-van den Hoek DW, et al. Among authors: pepels mjae. Support Care Cancer. 2023 Feb 23;31(3):184. doi: 10.1007/s00520-023-07625-6. Support Care Cancer. 2023. PMID: 36820944 Free PMC article.
Variability of cost trajectories over the last year of life in patients with advanced breast cancer in the Netherlands.
Schneider PP, Pouwels XGLV, Passos VL, Ramaekers BLT, Geurts SME, Ibragimova KIE, de Boer M, Erdkamp F, Vriens BEPJ, van de Wouw AJ, den Boer MO, Pepels MJ, Tjan-Heijnen VCG, Joore MA. Schneider PP, et al. Among authors: pepels mj. PLoS One. 2020 Apr 9;15(4):e0230909. doi: 10.1371/journal.pone.0230909. eCollection 2020. PLoS One. 2020. PMID: 32271794 Free PMC article.
Off to a good start after a cancer diagnosis: implementation of a time out consultation in primary care before cancer treatment decision.
Noteboom EA, de Wit NJ, van Asseldonk IJEM, Janssen MCAM, Lam-Wong WY, Linssen RHPJ, Pepels MJAE, Schrama NAWP, Trompper MEH, Veldhuizen LM, Wijtvliet AP, Zeldenrust EGF, Hendrikx AM, van de Boomen WA, Elbersen DM, Jacobs EMG, van der Wall E, Helsper CW. Noteboom EA, et al. Among authors: pepels mjae. J Cancer Surviv. 2020 Feb;14(1):9-13. doi: 10.1007/s11764-019-00814-5. Epub 2019 Nov 16. J Cancer Surviv. 2020. PMID: 31734854 Free PMC article.
25 results